So, Ojjaara/Omjjara sales amounted to $150 million in the fourth quarter of 2024, more than tripling year-on-year. While sales of the HIV therapy called Cabenuva also did not disappoint ...

New blood cancer drug Ojjaara/Omjjara generated £118 million in product sales compared with £98 million in third-quarter 2024. While the drug was approved by the FDA in September 2023 ...

GSK announced on Monday that Omjjara, its brand name for momelotinib, has been granted marketing authorisation by the European Commission, giving the company permission to market the drug and make ...

At its November meeting, the CHMP recommended the drug under the Omjjara trade name for the treatment of disease-related splenomegaly or symptoms in adult patients with moderate-to-severe anaemia ...